VAV Lipids enters Turkish Pharmaceutical market

VAV Life Sciences, a globally recognized company specializing in advanced lipid technologies, including mRNA-based formulations used in COVID-19 vaccines, has entered the Turkish market.

VAV Life Sciences, a globally recognized company specializing in advanced lipid technologies, including mRNA-based formulations used in COVID-19 vaccines, has entered the Turkish market. Through its strategic partnership with Arisan Kimya, the company will offer specialized lipid solutions in pharmaceuticals, personal care, nutrition and nanomedicines.